# VitaGraph Roadmap

This document outlines the research vision and planned feature development for VitaGraph. Features are organized by priority and release target.

---

## Version 0.2.0 (Current)

✅ **Released**: Synthetic-data pipeline with knowledge-graph and model-evaluation framework

### Features
- ✅ Synthetic biometric time-series generation (heart rate, HRV, sleep, environmental exposure)
- ✅ Circadian pattern simulation and signal processing (smoothing, outlier removal)
- ✅ Knowledge-graph construction (NetworkX) with multiple node/edge types
- ✅ Pluggable ML models (Linear, Random Forest, Gradient Boosting)
- ✅ Cross-validation and held-out test evaluation
- ✅ CLI interface (run, train, predict subcommands)
- ✅ Graph export (JSON, GraphML)
- ✅ Rule-based intervention prioritization (heuristic, not causal)
- ✅ Comprehensive test suite (20+ unit tests, ≥80% coverage)
- ✅ Full documentation (METHODOLOGY, ROADMAP, API reference)

---

## Version 0.3.0 (Q3 2026)

### Graph Neural Networks (GNNs)

**Objective**: Learn node embeddings from the knowledge graph structure, end-to-end.

**Why**: Individual features (heart rate, sleep) carry information, but their **relationships** and **temporal evolution** are equally important. A GNN can:
- Automatically learn which edges matter (person → HR vs. person → environment)
- Capture multi-hop neighborhoods (person's HR influenced by environmental exposure)
- Leverage the graph structure as an inductive bias

**Scope**:
- Implement a simple Graph Convolutional Network (GCN) or GraphSAGE
- Per-node predictions (biological age for each person)
- Feature attribution via attention weights
- Comparison vs. tabular baselines (do GNNs outperform?)

**Dependencies**: `torch`, `torch_geometric` or `deep_graph_library`

**Testing**: Unit tests on small synthetic graphs; benchmark on synthetic 100-1000 node graphs

---

## Version 1.0.0 (Q4 2026)

### Causal Inference

**Objective**: Estimate causal effects of modifiable risk factors on biological age.

**Why**: Current rule-based heuristic (v0.2) identifies correlations, not causation. A person with low sleep and high heart rate may have high biological age because:
1. Low sleep causes high HR and aging (causal), OR
2. An unobserved confounder (chronic stress) causes both low sleep and aging

Causal inference methods attempt to disentangle these scenarios.

**Scope**:
- **Instrumental variables (IV)**: If available (e.g., shift work exposure affects sleep but not age directly)
- **Propensity-score matching**: Match individuals similar on all confounders but differ on intervention
- **Causal forests**: Double/debiased machine learning (Chernozhukov et al.)
- **Doubly robust estimation**: Combines outcome modeling + propensity scoring

**Limitations**:
- Requires stronger assumptions (no unmeasured confounding)
- Results are estimates with confidence intervals, not certainties
- Real validation still requires RCT or long-term observational data

**Output**: Causal-effect estimates + uncertainty intervals

---

## Version 1.1.0 (Q1 2027)

### Federated Learning

**Objective**: Train models on distributed data without centralizing raw biometric information.

**Why**: Clinical data is sensitive and regulated (HIPAA, GDPR). Federated learning allows hospitals/clinics to collaboratively train a model while keeping data on-site.

**Scope**:
- Central server maintains a global model
- Each site trains locally on its data, sends only gradient updates
- Server aggregates gradients (FedAvg algorithm)
- Differential privacy: add Laplace/Gaussian noise to gradients before upload

**Challenges**:
- Convergence can be slower than centralized training
- Systems complexity (communication, synchronization)
- Validation on real heterogeneous data distributions

---

## Version 1.2.0 (Q2 2027)

### Real Data Integration

**Objective**: Extend VitaGraph to integrate real wearable devices, EHRs, and genomic data.

**Scope**:
- Connectors for common wearable APIs (Apple HealthKit, Google Fit, Oura Ring)
- EHR extraction (FHIR standards, HL7 parsing)
- Genomic data: SNP integration from 23andMe, AncestryDNA, or clinical labs
- Data harmonization pipeline (unit conversions, missing-value handling, outlier flagging)

**Ethical/Legal**:
- Informed consent UI/workflow
- HIPAA/GDPR compliance documentation
- Data anonymization & de-identification
- Right-to-deletion implementation

**Output**: Real-world validation of models trained in v0.2–v1.1

---

## Version 2.0.0 (2028)

### Multi-Omic Integration & Causal Biology

**Objective**: Go beyond biometrics to integrate genomics, proteomics, metabolomics, and transcriptomics.

**Scope**:
- **Genomic**: GWAS associations, rare-variant burden tests, PRS (polygenic risk scores)
- **Epigenomic**: DNA methylation clocks, histone modifications
- **Transcriptomic**: RNA-seq from blood or tissue, cell-free RNA
- **Proteomic**: High-throughput protein panels (e.g., SomaScan)
- **Metabolomic**: Targeted LC-MS or untargeted metabolomics

**Graph Enhancement**:
- Node types: Variant, Gene, Protein, Metabolite, Phenotype
- Edge relations: ENCODES, INTERACTS_WITH, ASSOCIATED_WITH
- Enables network pharmacology (which drugs perturb which networks?)

**ML Advances**:
- Multi-task learning (predict age + disease susceptibility + lifespan simultaneously)
- Deep learning on raw omic data (CNNs for sequences, autoencoders for high-dimensional profiles)
- Interpretability: SHAP/attention for omic contributions to age

---

## Long-Term Vision (2029+)

### Reinforcement Learning for Dynamic Interventions

**Objective**: Personalized treatment planning that adapts as new data arrives.

**Problem**: A person's biological age, sleep, HR, and environment change over time. A fixed recommendation (e.g., "improve sleep") may become outdated. RL can:
- Model transitions between states (age, HR, sleep, environment)
- Learn a policy: given current state, recommend action A, B, or C
- Optimize cumulative reward (years of life, quality-adjusted life-years / QALYs)

**Challenges**:
- Real data is observational; RL assumes active intervention
- Requires long-term follow-up to validate policies
- Ethical: how to experiment safely on humans?

### Generative Models

**Objective**: Synthetic data that preserves real-world correlations and is privacy-preserving.

**Use case**: Researchers worldwide can download synthetic data that mimics a real cohort's distribution without exposing any individual.

**Methods**: Variational Autoencoders (VAEs), Generative Adversarial Networks (GANs), Diffusion models

### In Silico Clinical Trials

**Objective**: Simulate outcomes of interventions before real trials.

**Use case**: Combine causal + generative models to predict trial outcomes and optimize study design.

---

## Research Partnerships & Funding

We are actively seeking:

1. **Research collaborators** in gerontology, biostatistics, bioinformatics
2. **Clinical data partners** (hospitals, biobanks, longitudinal cohort studies)
3. **Funding** from research foundations (NIH, European Research Council, Gates Foundation, etc.)
4. **Industry partnerships** for wearable/genomics data integration
5. **Community support**: Individual donors support infrastructure & development (see [DONATE.md](https://github.com/Ciprian-LocalPulse/vitagraph/blob/main/DONATE.md))

**Contact**: Ciprian Stefan Plesca (@Ciprian-LocalPulse on GitHub)

---

## 💝 Support VitaGraph

Open-source research requires sustained funding. **[Support VitaGraph →](https://github.com/Ciprian-LocalPulse/vitagraph/blob/main/DONATE.md)**

Your contributions fund:
- Cloud infrastructure & GPU compute
- Data quality & model development
- Open-science publishing
- Global research community



---

## Success Criteria

By 2028, VitaGraph will be considered successful if:

1. ✅ **Reproducibility**: Code, data, results are fully reproducible; ≥80% test coverage maintained
2. ✅ **Real validation**: Predictions show correlation with clinical biological-age measures (epigenetic clocks) in an independent cohort
3. ✅ **Community adoption**: Used by ≥10 research groups for teaching or research
4. ✅ **Publications**: ≥3 peer-reviewed papers published using or extending VitaGraph
5. ✅ **Fairness**: No disparate impact across age, sex, ancestry, or socioeconomic groups
6. ✅ **Ethics**: Data privacy & consent frameworks are published and reviewed by an external IRB

---

## Contributing to the Roadmap

We welcome feedback, feature requests, and code contributions. Please:

1. Open a **GitHub Issue** to discuss a feature
2. Check the [CONTRIBUTING.md](https://github.com/Ciprian-LocalPulse/vitagraph/blob/main/CONTRIBUTING.md) guide
3. Submit a **pull request** with tests and documentation

---

**Made for Research** | *Transparency & Collaboration*

Last updated: 2026-07-18
